Quick Takeaways
- Opaleye Management Inc. filed SCHEDULE 13G for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
- Disclosed ownership: 10%.
- Date of event: 01 Apr 2026.
Opaleye Management Inc. - 01 Apr 2026 SCHEDULE 13G Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)
- Filing Manager
- Opaleye Management Inc.
- Reporting Manager
- Opaleye Management Inc.
- Symbol
- KTTA
- Shares outstanding
- 24,934,935 shares
- Disclosed Ownership
- 2,491,000 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Apr 2026, 20:25:00 UTC
- Date of event
- 01 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Opaleye Management Inc. disclosed 10% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 01 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Apr 2026, 20:25.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% | 2,491,000 | 0 | 2,491,000 | /s/ James Silverman | President | |
| Opaleye, L.P. | 10% | 2,491,000 | 0 | 2,491,000 | /s/ James Silverman | General Partner | |
| James Silverman | 10% | 2,491,000 | 0 | 2,491,000 | /s/ James Silverman | Individually |